MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...

Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at ...

WESTON, Fla. — Research has found benefit from a different way of screening some men for prostate cancer. Dr. Alberto Pieretti, a urologist with Cleveland Clinic Weston, said rather than standard ...

Investigators ran a simulation of a hypothetical group of 65-year-old men who were at risk for the cancer, as indicated by their prostate-specific antigen (PSA) levels. The costs and benefits of ...

October 16, 2009 — Clinicians should consider magnetic resonance imaging (MRI) for men who have elevated prostate-specific antigen (PSA) levels or some other "worrisome" prostate cancer variable, but ...

Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

Persistent need for systematic biopsy for those on active surveillance for early-stage prostate cancer. The impact of focal therapy tumor boards, including prostate magnetic resonance imaging ...

Socio-demographic, clinical, and genetic predictors of low versus high Gleason score among men with prostate cancer in the Detroit Research on Cancer Survivorship (ROCS) cohort. This is an ASCO ...